S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q2 2023

Deep Track Capital

Period: Q2 2023 Β· Filed: 2023-09-06
View on SEC EDGAR β†—
AUM
$2.16B
Total portfolio value
Positions
55
Reported securities
Top Holding
JAZZ
7.2% $155.0M
QoQ Changes
+0 / -0
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2023-09-06) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
JAZZJAZZ PHARMACEUTICALS PLC$155.0M7.17%$123.97$243.47+96.4%
7.2%
INSMINSMED INC$137.2M6.35%$21.10$111.60+428.9%
6.3%
IONSIONIS PHARMACEUTICALS INC$116.3M5.38%$41.03$81.80+99.4%
5.4%
TVTXTRAVERE THERAPEUTICS INC$113.2M5.24%$15.36$56.92+270.6%
5.2%
GPCRSTRUCTURE THERAPEUTICS INC$110.0M5.09%$41.57$53.45+28.6%
5.1%
IMVTIMMUNOVANT INC$102.8M4.76%$18.97$38.79+104.5%
4.8%
ITCIINTRA-CELLULAR THERAPIES INC$98.0M4.54%β€”β€”
4.5%
ALKSALKERMES PLC$93.9M4.35%$31.30$54.58+74.4%
4.3%
SWTXSPRINGWORKS THERAPEUTICS INC$93.0M4.30%β€”β€”
4.3%
DVAXDYNAVAX TECHNOLOGIES CORP$84.7M3.92%β€”β€”
3.9%
GERNGERON CORP$77.6M3.59%$3.21$1.36-57.6%
3.6%
PLRXPLIANT THERAPEUTICS INC$73.4M3.40%$18.12$1.17-93.5%
3.4%
BCYCBICYCLE THERAPEUTICS PLC$71.9M3.33%$25.52$4.35-83.0%
3.3%
VRNAVERONA PHARMA PLC$67.4M3.12%β€”β€”
3.1%
GHGUARDANT HEALTH INC$53.7M2.49%$35.80$167.98+369.2%
2.5%
FDMT4D MOLECULAR THERAPEUTICS IN$50.2M2.32%$18.07$13.00-28.1%
2.3%
AGENAGENUS INC$48.0M2.22%$32.00$3.49-89.1%
2.2%
BEAMBEAM THERAPEUTICS INC$42.1M1.95%$31.93$34.79+9.0%
1.9%
AUTLAUTOLUS THERAPEUTICS PLC$35.7M1.65%$2.38$1.58-33.6%
1.6%
NTLAINTELLIA THERAPEUTICS INC$34.1M1.58%$40.78$17.56-56.9%
1.6%
VRDNVIRIDIAN THERAPEUTICS INC$30.4M1.41%$23.79$19.40-18.4%
1.4%
NRIXNURIX THERAPEUTICS INC$29.9M1.39%$9.99$23.97+139.9%
1.4%
RPTXREPARE THERAPEUTICS INC$28.9M1.34%β€”β€”
1.3%
EDITEDITAS MEDICINE INC$28.4M1.32%$8.23$3.65-55.6%
1.3%
DYNDYNE THERAPEUTICS INC$28.1M1.30%$11.25$23.07+105.1%
1.3%
ANIPANI PHARMACEUTICALS INC$27.7M1.28%$53.83$86.03+59.8%
1.3%
AXSMAXSOME THERAPEUTICS INC$27.6M1.28%$71.86$244.31+240.0%
1.3%
PNTPOINT BIOPHARMA GLOBAL INC$25.2M1.17%β€”β€”
1.2%
EWTXEDGEWISE THERAPEUTICS INC$21.3M0.99%$7.75$39.56+410.4%
1.0%
ZURAZURA BIO LTD$20.7M0.96%$8.20$5.17-37.0%
1.0%

Quarter-on-Quarter Activity

New Positions

None this quarter

Exited Positions

None this quarter

Increased

None this quarter

Trimmed

None this quarter

← Back to Hedge Funds
Deep Track Capital Q2 2023 13F Filing β€” Holdings & Portfolio | MarketsFN